SepTec is developing and commercializing a revolutionary sample-to-answer sepsis diagnostic device.
SepTec is developing and commercializing a revolutionary sample-to-answer sepsis diagnostic device that can rapidly detect pathogens in whole blood.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 21, 2022 | Seed | €5M | 1 | — | — | Detail |
| Jan 12, 2021 | Grant | €2.40M | 1 |
European Innovation Council
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
European Innovation Council
|
— | Seed |